Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -209,000 | -540,000 | -198,000 | 199,100 | -987,274 |
| Other Working Capital | -9,000 | -1,101,000 | 305,000 | -1,372,960 | -280,798 |
| Other Operating Activity | 5,091,000 | 5,057,000 | 4,726,000 | 3,880,375 | 3,604,075 |
| Operating Cash Flow | $4,873,000 | $3,416,000 | $4,833,000 | $2,706,515 | $2,336,002 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -673,000 | -1,164,000 | -1,274,000 | -2,200,469 | -1,423,408 |
| Net Acquisitions | N/A | N/A | N/A | -62,219 | 740,829 |
| Purchase Of Investment | -117,000 | -120,000 | -1,000 | -8,296 | -2,987 |
| Other Investing Activity | -151,000 | -233,000 | -268,000 | 371,238 | -607,898 |
| Investing Cash Flow | $-941,000 | $-1,517,000 | $-1,543,000 | $-1,899,745 | $-1,293,464 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 325,611 | 38,834 |
| Debt Repayment | N/A | N/A | N/A | -273,762 | -103,059 |
| Common Stock Issued | N/A | N/A | N/A | 122,364 | 19,417 |
| Common Stock Repurchased | -2,110,000 | -1,107,000 | -1,154,000 | -1,545,099 | -353,985 |
| Dividend Paid | -1,378,000 | -1,222,000 | -1,234,000 | N/A | N/A |
| Other Financing Activity | -135,000 | 426,000 | -924,000 | 0 | -1,494 |
| Financing Cash Flow | $-3,623,000 | $-1,903,000 | $-3,312,000 | $-1,370,886 | $-400,287 |
| Beginning Cash Position | 746,000 | 737,000 | 748,000 | 5,570,651 | 3,596,607 |
| End Cash Position | 1,055,000 | 733,000 | 726,000 | 5,006,534 | 4,238,858 |
| Net Cash Flow | $309,000 | $-4,000 | $-22,000 | $-564,117 | $642,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,873,000 | 3,416,000 | 4,833,000 | 2,706,515 | 2,336,002 |
| Capital Expenditure | -1,063,000 | -1,282,000 | -1,340,000 | -2,262,688 | -1,460,748 |
| Free Cash Flow | 3,810,000 | 2,134,000 | 3,493,000 | 443,827 | 875,254 |